Manikandan M
Overview
Explore the profile of Manikandan M including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
12
Citations
17
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
M M, J A, K N N, Soman S, P S
RSC Adv
. 2025 Feb;
15(8):6171-6182.
PMID: 40008022
Dye-sensitised solar cells (DSCs) possess promising features such as high performance under low-light conditions, cost-effectiveness, and adaptability in contrast to conventional silicon-based solar cells. Introducing a scattering layer has been...
2.
M M, Chhatar S, Dey S, Panda T, Chakraborty S, Ray P, et al.
ACS Med Chem Lett
. 2024 Sep;
15(9):1482-1490.
PMID: 39291013
Cancer is a multifaceted disease involving various pathological processes, including uncontrolled proliferation, development of resistance, angiogenesis, metastasis, etc. Therefore, chemotherapeutic agents capable of simultaneously inhibiting proliferation, circumventing chemoresistance, and inhibiting...
3.
M M, Das S, Barik A, Raj S, Mishra M, Rath S, et al.
Angle Orthod
. 2024 Sep;
94(5):522-531.
PMID: 39230014
Objectives: To examine dentoalveolar changes following intrusion of maxillary incisors with one or two anterior miniscrews in subjects with gummy smile and deep bite. Materials And Methods: Forty-three subjects were...
4.
R M, M D B, N B, S N, N A, M M, et al.
Heliyon
. 2024 Aug;
10(15):e35279.
PMID: 39170234
In recent years, additive manufacturing has increased in prominence as a primary method of manufacturing around the globe. Modern metal additive manufacturing presents an innovative approach to manufacturing complex structures...
5.
Phadte P, Bishnu A, Dey P, M M, Mehrotra M, Singh P, et al.
J Exp Clin Cancer Res
. 2024 Aug;
43(1):222.
PMID: 39123206
Background: The mechanisms enabling dynamic shifts between drug-resistant and drug-sensitive states in cancer cells are still underexplored. This study investigated the role of targeted autophagic protein degradation in regulating ovarian...
6.
Ketkar R, Dey P, Sodnawar T, Sharma S, M M, Dutta Choudhury S, et al.
Chem Asian J
. 2024 Mar;
19(9):e202400144.
PMID: 38487959
A short monodisperse poly(ethylene glycol) (PEG) and a neutral organic rotamer conjugate TEG-BTA-2 amphiphile was designed for the construction of a stimuli-responsive switchable self-assembled structure for drug encapsulation by noncovalent...
7.
M M, Chhatar S, Gadre S, Paul S, Vaidya S, Khatri S, et al.
Chemistry
. 2023 Oct;
30(4):e202302720.
PMID: 37888749
The impact of kinetic lability or reactivity on in vitro cytotoxicity, stability in plasma, in vivo tumor and tissue accumulation, and antitumor efficacy of functional platinum(II) (Pt) anticancer agents containing...
8.
Gadre S, M M, Chakraborty G, Rayrikar A, Paul S, Patra C, et al.
J Med Chem
. 2023 Oct;
66(19):13481-13500.
PMID: 37784224
While the phenomenal clinical success of blockbuster platinum (Pt) drugs is highly encouraging, the inherent and acquired resistance and dose-limiting side effects severely limit their clinical application. To find a...
9.
Panda T, M M, Vaidya S, Chhatar S, Sinha S, Mehrotra M, et al.
Angew Chem Int Ed Engl
. 2023 Jun;
62(38):e202303958.
PMID: 37314332
Even in the modern era of precision medicine and immunotherapy, chemotherapy with platinum (Pt) drugs remains among the most commonly prescribed medications against a variety of cancers. Unfortunately, the broad...
10.
M M, Gadre S, Chhatar S, Chakraborty G, Ahmed N, Patra C, et al.
J Med Chem
. 2022 Dec;
65(24):16353-16371.
PMID: 36459415
Emergence of resistance in cancer cells and dose-limiting side effects severely limit the widespread use of platinum (Pt) anticancer drugs. Multi-action hybrid anticancer agents that are constructed by merging two...